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Healthcare delivery around the world is advancing to value-based 
models. The reimbursement structure for the delivery of care in 
South Africa (SA)’s private sector is predominantly fee for service. 
Such models are recognised for favouring volume of care services 
over value of care services, where a value unit of care is defined as the 
quality outcomes achieved per costs incurred in the delivery of care.[1]
Discovery Health (DH), an administrative funder of healthcare in 
SA, routinely measures certain quality outcomes such as standardised 
mortality rates (SMRs) and shares these with providers of care 
for the purpose of healthcare improvement. Owing to DH’s role 
in the funding of healthcare, measurement of outcomes is based 
predominantly on service claims data. Where other sources of data 
are used, such as audits of case notes and administrative data, these 
are limited in application and used to support claims analysis.
Mortality is a sentinel outcome measure of quality of care and 
is helpful in understanding the performance of healthcare systems 
for the purpose of improvement. The measurement of SMRs occurs 
across hospitals that serve members of schemes administered by DH, 
referred to as ‘client schemes’. We share these results with hospitals 
and health professional care teams through standardised reports. 
Our intention is to demonstrate variation in care patterns to spur 
improvement. We hold the view that sharing SMRs with hospitals 
and care teams will support improvement efforts in the reduction of 
preventable deaths associated with acute inpatient care.
For the purpose of assessing variation of SMRs between hospitals, 
risk-adjustment methods are applied to source service claims data. 
The single goal of risk-adjustment SMR models is to accurately 
consider and adjust for patient clinical and demographic factors, 
so-called ‘demand-side factors’ that may skew results owing to 
disproportionately weighted demand factors across hospitals.[2-4]
Objectives
To describe and evaluate the validity of risk-adjustment methods 
applied to claims data to accurately determine condition-specific 
SMRs of individual hospitals in the private sector in SA, allowing for 
comparison of SMRs between hospitals.
Methods
Condition-specific mortality rates
The SMRs were calculated for specific conditions. The Agency 
for Healthcare Research and Quality (AHRQ) (the health services 
research arm of the US Department of Health and Human Services) 
has constructed a set of measures that provide a view on hospital 
quality of care using administrative data, called inpatient quality 
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indicator (IQI) mortality measures.[5] Conditions for reporting are 
chosen based on variation in mortality rates across the USA, 
suggesting that high mortality may be associated with deficiencies 
in quality of care. From the IQI list, we chose to initially measure 
pneumonia, stroke, acute myocardial infarction (AMI) and coronary 
artery bypass graft (CABG) procedures as relevant to the SA private 
sector setting. These four conditions collectively contributed to 
14% of all deaths (for individuals aged ≥18 years) occurring within 
30 days of an admission and 3.1% of all discharges during the years 
2014, 2015 and 2016 (DH administrative claims data, 2014 - 2016, 
unpublished). By concentrating on the SMRs for specific conditions, 
we hope to contribute meaningfully to the focused approach by 
hospitals and care teams to optimising the management of these and 
related conditions.
Definitions
The SMRs for specific conditions were calculated as follows (AHRQ 
Quality Indicators, 2016[5]):
Sum of all deaths for the specific condition within 30 days from 
admission to the hospital 
All admissions at the same hospital for the same specific conditions 
over the same period
All causes of death were measured as an outcome, within 30 days of 
admission for that specific medical condition or procedure. Thirty 
days from admission is considered an appropriate time frame in 
which a death may reasonably be attributed to care in hospital, the 
transitional period to a non-acute setting and suitability of the patient 
for discharge.[6] Quality of care can affect outcomes in a 30-day 
time frame, and many current hospital interventions are known to 
decrease the risk of death within 30 days of an admission.[7] The 
concept that evaluating an outcome using a standardised period such 
as 30 days complies with standards for such measures and is included 
in scientific statements by the American College of Cardiology and 
the American Heart Association.
The metric of death within 30 days of admission is counted 
irrespective of whether death occurred in or out of hospital, and 
is chosen instead of inpatient deaths only to ensure a consistent 
measurement time frame from admission, as length of hospital stay 
varies across patients and hospitals.
The denominator: Included population
The data used to calculate the condition-specific mortality rates were 
obtained from claims data submitted to client schemes of DH for a 
3-year period from 2014 to 2016. The included population in the 
denominator calculation for stroke, pneumonia or AMI had to be 
>18 years of age, and hospitalised during the measurement period 
with a principal discharge diagnosis of stroke, pneumonia or AMI. 
The included population age requirement for inclusion for CABG 
was >40 years. Members were excluded from the cohort if discharged 
against medical advice (refused hospital treatment), or if pregnant.
To allow for a full view of claims data regarding comorbid diseases 
and other clinical risk factors, members who met the criteria for the 
included population further had to have been enrolled in the client 
scheme for at least 12 months prior to the admission used in the 
included population sample.
For specific conditions, criteria unique to the condition were 
applied in determining suitability of inclusion in the included 
population. For AMI and pneumonia, patients discharged alive 
on the day of the admission or the subsequent day, who were not 
transferred to another acute hospital, were excluded from the 
included population.[6] The rationale for this exclusion is based on 
the notion that given the very short hospitalisation of these cases, it is 
questionable whether the clinical diagnosis of AMI and pneumonia 
was accurate, resulting in the exclusion of such cases.
Internationally, ischaemic strokes are the most common type of 
stroke and account for the majority of stroke hospitalisations. In our 
data set for the 2014 - 2016 period, ischaemic strokes accounted for 
92% of strokes. The causes, prognosis and treatment of ischaemic 
stroke can be quite different from those of haemorrhagic stroke, 
making the stroke cohort mixed if the two stroke types are combined. 
This heterogeneous picture is further confounded by differences in 
risk factors, making the risk adjustment difficult in this combined 
scenario. Haemorrhagic strokes were therefore excluded from the 
stroke population, with only ischaemic strokes included.
Only isolated CABG procedures were included in the calculation 
of CABG SMRs. Isolated CABG surgeries were defined as CABG 
procedures performed without concomitant valve or other major 
cardiac, vascular, or thoracic procedures.
For members transferred from one facility to another where a 
death occurred, such a death can only be assigned to one of these 
facilities. In these situations the first hospital, considered the first 
entry point into the healthcare system, was allocated the death if the 
patient was transferred from that hospital >24 hours after the initial 
admission. If the transfer occurred within 24 hours, the receiving 
hospital was accountable for the outcome of the patient.[6]
To avoid survival bias and to comply with model independence, 
for each condition one admission was randomly selected during the 
3-year rolling period of data collection for patients with multiple 
admissions for the same diagnosis during this time. This was 
performed using simple random sampling without replacement in R, 
with a set seed value of 50. While patients with multiple admissions 
are anticipated to have an increased morbidity profile, this is 
accounted for by the ACG Resource Utilisation Band and Truven’s 
disease staging risk factors (Table 1).
Hospitals with <25 cases for the diagnosis of any one of the four 
conditions during the 3-year rolling period were not reported on for 
that condition.
The numerator: Identifying deaths
The claims data used to calculate the condition-specific SMRs were 
analysed through a manual auditing process to confirm that the 
death did occur. All deaths were identified by a withdrawal from 
the client scheme with reason provided for death,  International 
Statistical Classification of Diseases and Related Health Problems 
(ICD-10) coding of death on claims data (hospital-submitted claims 
or provider claims), or submission of a death certificate to the client 
scheme for the purpose of withdrawal from the scheme. Such errors 
are mainly due to administrative issues or human error factors 
involving incorrect dates of death captured on death certificates 
by the Department of Home Affairs, or issues of delayed member 
withdrawal from client schemes. For this data period, 18 203 deaths 
were audited and 16 446 were deemed true and included in the 
cohort (numerator) for the specified conditions.
Statistical analysis to achieve case risk adjustment:  
A two-stepped approach
Certain clinically high-risk members may be vulnerable to death 
during or shortly after an admission, given the associated underlying 
clinical risk profile. As such, an analysis of the impact of a hospital 
system on the probability of death needs to account for the impact 
of individual differences in the clinical risk profile of the treated 
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population. A statistical risk-adjustment model is developed to 
understand, for the general admitted population, its relative risk of 
dying and the various risk factors that influence the probability of 
death. The relative distribution of individual risks for each hospital 
system is then statistically modelled to obtain a relative risk score per 
hospital after accounting for the individual patient differences. There 
are therefore two steps to the risk-adjustment approach.
In brief, the two-stepped modelling approach models data at the 
patient level and subsequently at a hospital system level to account for 
the variance in SMRs within and between hospitals.
The patient-level model
The relative risks for each individual were estimated by means of 
the gradient boosting machine (GBM) family of models. A linear 
mixed model was then used to estimate the relative risk score per 
hospital, adjusted for the individual risks as determined by the 
GBM model.
The GBM model is a newer machine learning model that, 
in general, segments the data in more accurate risk cells and 
consequently provides stronger prediction power than conventional 
statistical regression. Generally, GBM models are an ensemble family 
in that they combine a collection of simpler models to generate 
a prediction from the combination. The term ‘boosting’ in the 
model title describes the method of choosing the simpler models. 
Each subsequent model is chosen on the basis that it improves 
the prediction of observations currently poorly predicted by the 
available set of simple models. As the outcome of this study was a 
binary variable (death = yes/no), the class of simpler models used 
was the decision tree. Elith et al.[8] provide an accessible description 
of the features of this subclass of the GBM family of models. All 
predictive models are at risk of over-fitting the model to the data. 
The GBM family of models addresses this risk in a number of 
ways. The approach of using simple models is generally resistant to 
over-fitting,[9] but in addition this can be reduced by stochastically 
selecting subsamples for the fitting of each simple tree and similarly 
stochastically selecting subsets of the independent variables for each 
pass. Finally the results are assessed using an independent validation 
sample distinct from the training sample.[10]
This GBM model is used to predict the probability of mortality 
(within 30 days of admission for medical admissions and within 
30  days of the procedure date for CABG). Models were fitted on 
randomly selected 2009 - 2013 client scheme data, referred to as 
the training data. These trained models were then tested on the 
remaining 30% of 2009 - 2016 client scheme data, the output of this 
being referred to as the testing data.
The GBM model includes as predictors age at admission date, 
gender, base diagnosis-related grouper (DRG) of the evaluated 
admission, base DRG disease stage (as per the Truven model), 
clinical emergency (ICD-10 as per PMB (Prescribed Minimum 
Benefit) billed on event), resource utilisation bands (12 months prior 
to admission month), count of prior relevant events per month (last 
12 months prior to event month), and all validated chronic disease 
staging conditions (as per the Discovery episode grouper) and 
Truven disease stage of that condition 12 months prior to the event 
(only where ≥10 patients have a stage for this condition).[11,12]
In this analysis, the GBM model predicts at a higher level of 
accuracy for the four medical conditions and surgical procedures 
than a linear model of the same data. This is evident from the 
operating characteristic curves in Figs 1 - 4, which show that the test 
dataset has better precision (probability that a predicted positive is 
in fact a true positive) and recall (or specificity, the probability that a 
true positive is identified as such) for the whole range of the predicted 
probability.
The hospital system-level model
The second step of the two-step model is at the hospital system 
level, and models the hospital-specific effects as a term in the model 
indicating the degree to which patients in a given hospital have a 
higher or lower risk of death after adjusting for the estimated patient 
risk of death based on the outcomes of the model in step 1. As such, 
the hospital system effect represents the underlying risk of mortality 
at the hospital, after accounting for patient clinical risk. In particular, 
the probability scores from the first model for the measurement 
period of 2014 - 2016 were used as a covariate to create the final 
relative risk score per hospital system, which is the metric that we 
report on.
The distribution of hospital-specific effects is estimated to account 
for the clustering (non-independence) of patients within the same 
hospital. If there are no differences among hospitals, after adjusting 
for patient risk, the hospital system effects should be identical across 
Table 1. Definitions of tools utilised for risk-adjustment purposes
• Discovery Health (DH) diagnosis-related group (DRG). The DRG grouper is a patient classification system that provides means of clustering 
clinically similar admissions into groups that are expected to have a similar resource usage. The grouper uses diagnostic and procedure codes 
to classify admissions into a small number of major diagnosis categories which are then subdivided into more specific groups (DRGs) and then 
into narrower groups, based on the presence of complications or comorbidities. We used version 8 of the DH DRG.
• Johns Hopkins adjusted clinical groups (ACGs). The Johns Hopkins University ACG system is an internationally recognised method for 
grouping patients of similar clinical complexity and disease burden and therefore expected healthcare resource utilisation. The Johns Hopkins 
ACGs group beneficiaries into one of 93 distinct groups based on expected healthcare resource utilisation from the point of diagnosis, over a 
specified period (typically 12 months).
• Resource utilisation band (RUB). The ACG system automatically assigns patients to a hierarchical six-level morbidity category, called RUBs. 
The six RUBs (low to high) are formed by combining the ACG mutually exclusive cells that measure overall morbidity burden.
• Discovery episode grouper (DEG). The DEG is software technology using proprietary logic to organise claims data into diagnostically and 
chronologically related episodes of care. Episodes of care are periods of treatment. They are initiated by a healthcare practitioner when a patient 
first presents for care and a diagnosis is made. The episode continues to the resolution of a condition/illness/disease. International Statistical 
Classification of Diseases and Related Health Problems (ICD-10)-coded diagnoses are grouped together to construct an individual’s encounter 
with the healthcare system into episodes of care.
• Truven’s disease staging grouper. The Truven’s disease staging grouper is a classification system that uses diagnostic findings (ICD-10 codes) to 
produce clusters of patients who require similar treatments with similar expected outcomes. Disease staging is a method for measuring the severity 
of a specific disease. A disease is a well-defined process model of disruption in the normal homeostasis of physiological or psychological system.
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all hospitals and as such the outcomes 
should show no more than random 
variation across the hospitals. However, 
if the variation between hospitals is non-
negligible, the effect size for each hospital 
reflects the relative risk for patients in that 
hospital.
To report the findings, the random effect 
for each hospital was estimated and a 90% 
confidence interval (CI) was generated 
per hospital, given its underlying patient 
distribution. Hospitals were noted where 
the effect size was significantly different 
from 0 (0 falls in the CI), indicating that the 
hospital had significantly better or worse 
performance than the pool of hospitals.
The random effects estimator is a 
shrinkage estimator where the mean shrinks 
towards the global mean in the case of 
a small number of observations for that 
particular hospital. This has the advantage 
that hospitals with few results are not 
inadvertently penalised (or provided undue 
benefit) owing to a few unusual results.
Bedside case notes verification of 
case risk adjustment
Internationally, clinical case review of bed-
side case notes is widely used to validate 
administrative claims data that have been 
risk-adjusted, to determine accuracy of the 
fit of claims data as a proxy for clinical 
outcomes data such as those provided 
through registries, in determining condition-
specific SMRs.[13] A clinical team undertook 
to achieve this purpose to validate the case 
risk-adjustment findings of the GBM model. 
A retrospective review of hospital case 
files was done on a random sample of 271 
members across 54 hospitals from the data 
set used in the GBM model.
The case notes review sought specifically 
to verify the accuracy of comorbid 
conditions that were used in the claims 
case risk-adjustment purposes, and there-
fore to determine alignment between 
claims case risk adjustment and clinical 
risk stratification. Data obtained from this 
verification process showed that 82.2% of 
comorbid diseases described in bedside 
notes were accounted for in the claims risk 
adjustment for the four conditions chosen. 
The pneumonia cohort had risk factors 
that were 96.6% matched, while CABG 
was 90.5% matched. AMI and stroke had 
risk factors that were 75% and 72% factor 
matches, respectively. It is not possible to 
comment on the relevance of mismatched 
factors between the claims risk adjustment 
and the clinical case notes review without a 
review of the treating health professional’s 
files. It is worth noting that it is unlikely 
that comorbid conditions exist that are not 
captured through claims analysis, as claims 
need to be submitted for reimbursement 
of clinical services and for the entitlement 
of benefits. However, it remains possible 
that other patient records outside claims 
submitted to client schemes may include 
conditions not captured in the history of 
submitted claims and administrative data, 
and such conditions could have a bearing on 
the claims case risk adjustment.
Results
Following clinical risk adjustment 
of the data and the resulting output of 
hospital- level SMRs, each hospital system 
is analysed relative to the average of all 
hospitals analysed. The total cohort of 
hospitals analysed is regarded as a national 
representation, so each individual hospital 
SMR is reported on as follows:
• More deaths than the national average
• Deaths no different from the national 
average
• Fewer deaths than the national average.
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Fig. 1. Acute myocardial infarction precision recall graph. (GLM = generalised linear model; GBM = 
gradient boosting machine.)
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Fig. 2. Stroke precision recall graph. (GLM = generalised linear model; GBM = gradient boosting 
machine.)
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The national average referred to here is the 
average of SMRs for all hospital systems in 
our analysis, which is restricted to members 
of client schemes of DH included in the 
numerator and denominator populations as 
defined elsewhere in the article.
For the measurement period January 
2014 - December 2016, for which the risk-
adjusted SMRs are calculated, a total of 8 809 
admissions for stroke, 29 159 admissions 
for pneumonia, 5 791 admissions for AMI 
and 2 955 cases of CABG were included in 
the data. The numbers of deaths for these 
conditions over the time period evaluated 
were 707, 1 556, 564 and 95, respectively.
The average mortality rates for AMI, 
stroke, pneumonia and CABG were 9.7%, 
8.0%, 5.3% and 3.2%, respectively. While 
the aim is not to compare with international 
benchmarks, it is interesting to note that 
none of these rates is alarming in compari-
son. The rates measured in the SA setting 
compared with the US setting are either 
similar or lower for the four conditions. 
The mortality rates across all hospitals with 
>25 admissions for the particular condition 
during the data period ranged as follows: 
CABG 0 - 14.5%, AMI 0 - 32.1%, stroke 0 - 
34.8% and pneumonia 0 - 17.7%.
All hospitals with adequate numbers of 
cases for calculation of a mortality rate in 
the CABG and AMI categories were deemed 
to have mortality rates no different from 
the national average. For pneumonia and 
stroke, some variation in terms of hospital 
performance was evident, as illustrated in 
Table 2.
Discussion
Donabedian’s[14] component approach to 
evaluating the quality of care delivered by 
healthcare systems is the foundation of 
measuring quality for the improvement of 
healthcare systems. The three Donabedian 
components of quality are structure, 
process and outcome measures. Each of 
these components is important to measuring 
and improving quality, but according to 
Donabedian,[14] and similar to Michael 
Porter’s[1] construct of value-based health-
care, outcome measures remain the ‘ultimate 
validators’ of the effectiveness of healthcare. 
Quality outcomes can be difficult to define 
and there may be time lags from initiation 
of an improvement to its materialising in a 
commensurate improvement in an outcome. 
Tracking outcome measures over time as 
well and presenting this information to 
healthcare providers is fundamental to 
developing sustainable changes in healthcare 
systems.
Mortality due to illness is the single most 
important and serious outcome measure 
of care. The reality is that some individuals 
die despite receiving the best care possible. 
Measuring mortality rates allows us 
to determine whether more deaths have 
occurred than would ordinarily be expected. 
However, for mortality to be a meaningful 
and fair hospital system indicator, we 
need to take account of differences in the 
case-mix of patients and system-related 
factors that may influence the likelihood of 
dying. This adjusted measure may help to 
avoid preventable deaths in the future by 
contributing to the evaluation of hospital 
performance, providing accountability, 
guiding improvement programmes, 
and informing further research that will 
contribute to improving the safety and 
quality of care in hospitals.
Certain conditions requiring acute care in 
hospital are more susceptible than others to 
preventable deaths resulting from hospital 
system gaps. This situation is evidenced 
through variation in mortality rates across 
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Fig. 3. Pneumonia precision recall graph. (GLM = generalised linear model; GBM = gradient boosting 
machine.)
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Fig. 4. Coronary artery bypass graft precision recall graph. (GLM = generalised linear model; GBM = 
gradient boosting machine.)
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hospital care systems. This article describes a model that uses claims 
data to compare risk-adjusted SMRs for specific conditions at hospital 
system level towards developing an understanding of patterns of 
variation in quality of care delivered in the private healthcare 
setting in SA. Our goal is to support and spur improvement through 
transparently sharing these results with providers of care. It is our 
view that gaps that are highlighted in the delivery of care present 
an opportunity for learning and improvement. International studies 
have shown that reporting of mortality measures does lead to 
improvements in the quality of care delivered.[15]
This exercise of examining variation in SMRs at hospital system 
level is the first of its kind in SA’s private sector. These results are not 
benchmarked against internationally reported mortality findings; 
the purpose of the exercise is rather to examine the variation in 
SMRs across local private hospital systems that becomes a base from 
which performance can be strengthened. It is our understanding that 
the private healthcare system strives for excellence and continuous 
improvement. Our analysis of hospital systems relative to each other 
therefore allows for reflection by private hospitals and care teams on 
improvement strategies towards an improved national benchmark. 
This practice of clustering facilities in a country or region, and 
determining variation among the chosen group, is international in its 
scope and has been reported in many countries (USA, UK, Canada, 
Australia).[16-19]
Audited data were used to confirm that a death occurred. We used 
a claims data model that has been validated internationally[3,6,13,20] 
as a good proxy for clinical data, such as bedside case notes, for the 
purpose of risk adjustment. Our claims data only include information 
that is known about the patient from our administrative systems, 
including claims submitted for acute and chronic clinical services, 
and the registration of members for chronic conditions. If an 
insured member chooses not to be registered for a chronic disease 
or does not submit claims for acute or chronic clinical services 
incurred, the claims case risk adjustment is vulnerable to not being 
fully case risk-adjusted for that member by missing potential risk 
factors. Despite this drawback, the verification clinical case review 
process has illustrated that the claims data used to risk-adjust for the 
modelling conducted have an adequate alignment with the clinical 
case information. Other considerations include the quality of ICD-10 
coding that occurs.
While claims data may have limitations regarding case risk 
adjustment, it is important that we do not lose the opportunity 
to use claims data as a reliable proxy to comment on the quality 
of care within healthcare systems. We use this transparency of 
performance outcomes measures such as SMRs to support or 
improve the healthcare system. The results that are reported on are 
of the healthcare system as a whole, and not individual hospitals 
or individual health professionals. A single result cannot pinpoint 
reasons for a hospital’s SMR. Healthcare systems consisting of 
hospital teams and health professionals should use these data to 
initiate dialogue and processes to determine the reasons for that 
healthcare system’s SMR and what improvements are needed to 
improve quality of care. We advocate that even hospitals with the 
highest-performing SMRs strive to do better, as any continuing 
improvement framework would advise.
SMR results are currently shared with hospital and healthcare 
professionals. We intend to update the results on an annual basis and 
to share them with providers of care to support efforts to improve the 
quality of care delivered by healthcare systems.
Conclusions
It is our view that the measurement and reporting of quality of care 
outcome metrics, such as SMRs, is a valuable approach to enabling a 
culture of learning and continuous improvement within healthcare 
systems.
The method described in this article has not been described 
previously in the SA setting and shows that condition-specific 
mortality can be measured in a claims-based environment using 
a robust methodology adopted and adapted from international 
practice. While hospital groups and individual hospitals may struggle 
to replicate this particular claims-based methodology owing to lack 
of claims insight and access to data, other private sector medical 
funders can utilise this methodology to report, reflect and share 
these valuable outcomes. The tools used, as described in this article, 
were either proprietary to DH or proprietary to other international 
companies.
In the non-claims environment, clinical data such as bedside case 
notes available to hospitals and doctors can similarly be used to 
examine SMRs across hospital systems, for the purpose of initiating 
and tracking improvement.
The aim of this claims-based risk-adjustment methodology is 
not to compare local results against international benchmarks. 
Our intention with using this methodology is to establish a local 
distribution pattern that examines variation of SMRs across 
hospital systems, which is a standard approach in statistical quality 
improvement. Ultimately, one cannot improve on the unknown. 
Measuring quality outcomes in healthcare is important in ensuring 
that the consumer of healthcare services receives the best care 
possible. Not all deaths are preventable, but the goal of robustly 
measuring mortality is to encourage broad approaches to quality 
improvement to lower the general risk of mortality in hospital 
systems.
Table 2. Condition-specific standardised mortality rates for the period 2014 - 2016 across private hospitals in South Africa for 
members of Discovery Health client schemes
Statistically significant classification of 
hospitals relative to the national AMR 
Pneumonia AMR* 
(5.3%)
CABG AMR*  
(3.2%)
Stroke AMR*  
(8.0%)
AMI AMR*  
(9.7%)
Better than (fewer deaths than the 
national average), n
6 0 2 0
No different, n 155 35 109 62
Worse than (more deaths than the 
national average), n
17 0 3 0
Hospitals with too few cases to be 
reported on, n
26 16 76 119
Total hospitals, N 204 51 190 11
AMR = average mortality rate; CABG = coronary artery bypass graft; AMI = acute myocardial infarction.
*The condition-specific AMR calculated during the relevant period using Discovery data.
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